NovelStem International Corp. (NSTM)
0.0095
0.00 (0.00%)
USD |
OTCM |
Sep 10, 16:00
NovelStem International Gross Profit (TTM) : 0.00 for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -0.445M |
| December 31, 2022 | -0.8302M |
| September 30, 2022 | -1.272M |
| December 31, 2013 | -1.272M |
| September 30, 2013 | -0.8271M |
| June 30, 2013 | -0.4419M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.224M |
| June 30, 2012 | 1.027M |
| March 31, 2012 | 2.076M |
| December 31, 2011 | 1.955M |
| Date | Value |
|---|---|
| September 30, 2011 | 2.643M |
| June 30, 2011 | 4.781M |
| March 31, 2011 | 7.069M |
| December 31, 2010 | 9.181M |
| September 30, 2010 | 11.40M |
| June 30, 2010 | 10.95M |
| March 31, 2010 | 10.90M |
| December 31, 2009 | 10.20M |
| September 30, 2009 | 8.809M |
| June 30, 2009 | 8.271M |
| March 31, 2009 | 8.563M |
| December 31, 2008 | 10.18M |
| September 30, 2008 | 12.39M |
| June 30, 2008 | 13.55M |
| March 31, 2008 | 14.59M |
| December 31, 2007 | 15.05M |
| September 30, 2007 | 16.57M |
| June 30, 2007 | 20.91M |
| March 31, 2007 | 20.02M |
| December 31, 2006 | 21.01M |
| September 30, 2006 | 19.57M |
| June 30, 2006 | 13.74M |
| March 31, 2006 | 16.41M |
| December 31, 2005 | 13.73M |
| September 30, 2005 | 15.38M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Brainstorm Cell Therapeutics, Inc. | -0.179M |
| Summit Therapeutics, Inc. | -0.174M |
| Kezar Life Sciences, Inc. | -0.693M |
| Protara Therapeutics, Inc. | -0.343M |
| Clene, Inc. | -1.295M |